Michael Holder Cytek Biosciences, Inc. (CTKB) insider trading activity

CTKB Quotes by TradingView

Michael Holder is of Cytek Biosciences, Inc.. Currently has a direct ownership of 10,178 shares of CTKB, which is worth approximately $39,897. The most recent transaction as insider was on Aug 18, 2025, when has been sold 2,181 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.2K
27.27% 3M change
600.0% 12M change
Total Value Held $39,897

Michael Holder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2025
BUY
Exercise of conversion of derivative security
-
2,181 Added 17.65%
10,178 Common Stock
May 19 2025
BUY
Exercise of conversion of derivative security
-
1,454 Added 15.38%
7,997 Common Stock
Mar 10 2025
BUY
Exercise of conversion of derivative security
-
2,908 Added 30.77%
6,543 Common Stock
Nov 18 2024
BUY
Exercise of conversion of derivative security
-
2,181 Added 37.5%
3,635 Common Stock
Aug 19 2024
BUY
Exercise of conversion of derivative security
-
1,454 Added 50.0%
1,454 Common Stock

Also insider at

RCEL
AVITA Medical, Inc. Healthcare
Chief Financial Officer
MH

Michael Holder

Valencia, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTKB